Böhner H, Zimmer T, Hopfenmüller W, Berger G, Buhr H J
Department of General, Thoracic and Vascular Surgery, Freie Universitat Berlin, Germany.
Hepatogastroenterology. 2000 Sep-Oct;47(35):1489-94.
BACKGROUND/AIMS: Although routine follow-up after surgery for gastric cancer is recommended its value after gastrectomy has not been evaluated.
All patients who underwent gastrectomy for gastric cancer entering the routine follow-up program between January 1987 and August 1996 were identified. The patients studied were those with either histologically proven recurrence or those in whom recurrence was highly probable from clinical course. Two groups were compared. The first group comprised the patients whose recurrence was detected by routine follow-up prior to the development of clinical signs (asymptomatic group). The second group consisted of the patients who developed clinical symptoms due to a recurrence that was detected subsequently (symptomatic group). The main parameters were the time until recurrence occurred, the pattern of recurrence, treatment and survival.
Out of 184 patients entering the routine follow-up 135 patients had undergone potentially curative gastrectomy. Sixty-seven patients (49.6%) had recurrences. Only 15 (22.3%) belonged to the asymptomatic group and 52 (77.7%) to the symptomatic one. The time until recurrence occurred was not different between the 2 groups (17.1 vs. 18.0 months). Chemotherapy was performed more frequently in the asymptomatic group and survival was longer (8.4 vs. 5.9 months). This difference was due to the time the patients remained asymptomatic (average 43 months). No effect of either early detection or chemotherapy was seen. In the asymptomatic group distant recurrence was common while recurrence in the symptomatic group was more often local but this difference did not reach statistic significance.
Routine follow-up after gastrectomy for gastric cancer does not contribute to early detection of gastric cancer recurrence. It has no benefit with respect to treatment and survival of patients with recurrent disease and should therefore be reduced to symptomatic and psychological aftercare.
背景/目的:虽然推荐对胃癌手术后进行常规随访,但胃切除术后其价值尚未得到评估。
确定了1987年1月至1996年8月期间进入常规随访计划的所有因胃癌接受胃切除术的患者。所研究的患者为组织学证实复发的患者或根据临床病程极有可能复发的患者。对两组进行了比较。第一组包括在出现临床症状之前通过常规随访检测到复发的患者(无症状组)。第二组由随后因复发出现临床症状的患者组成(有症状组)。主要参数为复发发生时间、复发模式、治疗和生存情况。
在进入常规随访的184例患者中,135例接受了根治性胃切除术。67例患者(49.6%)复发。只有15例(22.3%)属于无症状组,52例(77.7%)属于有症状组。两组之间复发发生时间无差异(17.1个月对18.0个月)。无症状组化疗更频繁,生存时间更长(8.4个月对5.9个月)。这种差异归因于患者无症状的时间(平均43个月)。未观察到早期检测或化疗的效果。在无症状组远处复发常见,而有症状组复发更常为局部复发,但这种差异未达到统计学意义。
胃癌胃切除术后的常规随访无助于早期发现胃癌复发。对于复发疾病患者的治疗和生存没有益处,因此应减少为有症状和心理方面的后续护理。